Skip to main content
OpenTrials
Completed

NCT Number: NCT01608633

Effects of Spray and Stretch on Postneedling Soreness and Sensitivity After Dry Needling of a Latent Myofascial Trigger Point.

Pain after dry needling or injection in the muscle is a frequent secondary effect in the treatment of myofascial pain syndrome. In this trial spray and stretch technique is evaluated as a method to reduce this soreness. As well, the characteristics and the different factors that influence in this pain will be described.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

CEU San Pablo University

Madrid, 28668, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects presenting latent trigger points in the trapezius muscle

Exclusion criteria

  • Subjects with active trigger points or absence of trigger points.

Treatment and study plan

Spray and stretch

Other

Physiotherapeutic technique which consist in stretching the muscle while a cold spray is applied on the skin.

Primary outcomes

  1. Pain

    Time frame: 72 hours

    Visual analogue scale

Secondary outcomes

  1. Pain

    Time frame: 48 hours

    Pressure pain threshold

  2. Psychological factors

    Time frame: 72 hours after needling

    Symptom check list revised. SCL-90-r

Sponsors and collaborators

Lead sponsor

CEU San Pablo University

Other

Registry information

Important dates

Study start
2012
Primary completion
2013
First posted
May 31, 2012
Registry last updated
Sep 4, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.